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Abstract
The commercialization of university-based research occurs to varying degrees
between academic institutions. Previous studies have found that multiple
barriers can impede the effectiveness and efficiency by which academic
research is commercialized. This case study was designed to better
understand the impediments to research commercialization at the University of
Kentucky via a survey and interview with three successful academic
entrepreneurs. The study also garnered insight from the individuals as to how
the commercialization process could be improved. Issues with
commercialization infrastructure; a lack of emphasis, at the university level, on
the importance of research commercialization; a void in an entrepreneurial
culture on campus; inhibitory commercialization policies; and a lack of business
and commercialization knowledge among faculty were highlighted as the most
significant barriers. The research subjects also suggested that
commercialization activity may generally increase if a number of factors were
mitigated. Such insight can be communicated to the administrative leadership
of the commercialization process at the University of Kentucky. Long term,
improving university-based research commercialization will allow academic
researchers to be more active and successful entrepreneurs such that
intellectual property will progress more freely to the marketplace for the benefit
of inventors, universities and society.
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            Amendments from Version 1
In response to the reviewers’ comments, we have made several 
changes of which the most substantial are that we have clarified 
the overall intent of the study, increased the sample size and we 
have added a description of the study’s limitations. We have also 
responded to each reviewers’ report below.
See referee reports
REVISED
Introduction
Research is a vital component of the mission of universities, and 
indeed academic institutions conduct a substantial volume of 
research that is funded by government, industry and philanthropic 
agencies. Development or the commercialization of research should 
also be a key component of the research mission such that novel 
ideas, techniques and products can enter the marketplace for the 
benefit of a variety of stakeholders including inventors, universities 
and society. In order to facilitate academic-based commercializa-
tion, legislation, such as the Bayh-Dole Act, provides universities 
the legal framework for commercializing the research that is devel-
oped within university settings1,2.
In a commercialization survey conducted by the Association of 
University Technology Managers (AUTM), in 2013, United States-
based institutions generated over 24,000 disclosures, obtained 
over 5,000 new patents, executed over 5,000 licensing agreements, 
formed over 800 start-up companies and generated $2.75 billion in 
license income3. Despite this overall success, academic research-
ers experience many issues that obstruct the commercialization 
of research within higher education settings. Previous studies at 
academic institutions have documented challenges to the commer-
cialization process that include, but are not limited to: risk aver-
sion; constraints on faculty time; lack of financial support; policy/ 
regulation barriers; infrastructure insufficiencies; lack of a common 
understanding of the value of research commercialization; lack of 
entrepreneurial thinking among faculty; and lack of interaction 
and collaboration between universities and industry4–10. A previous 
study at the University of Kentucky found that expense, time con-
straints, insufficient infrastructure and lack of industry partnerships 
were the most common factors experienced by cancer researchers 
that impede research commercialization11. Ultimately, challenges to 
the effective and efficient commercialization of research inhibits 
obtaining the maximum benefit of university research in that such 
barriers can prevent university-based innovation from progress-
ing to the marketplace for the benefit of inventors, universities and 
society.
The University of Kentucky commercializes its research through the 
Intellectual Property Development and Technology Transfer Office, 
a unit of the Office of the Vice President for Research. Through 
this office, the university’s research commercialization activities 
are historically modest compared to its benchmark institutions. The 
university currently ranks last among its benchmark institutions 
in regard to several commercialization metrics including in staff-
ing, invention disclosures, patent applications and license/options 
executed (Table 1). And, growth in commercialization activity has 
been relatively flat from 2010–2013 with the exception of a recent 
increase in license income (Table 2). These data could suggest that 
the University of Kentucky may experience additional commercial-
ization barriers as compared to its benchmark institutions and/or a 
higher magnitude of common barriers among institutions.
Table 1. University of Kentucky research commercialization metrics versus select benchmark institutions (2013)*.
Name of Institution Research Expenditures
Licensing 
FTE
Invention 
Disclosures
Patent 
Applications
Patents 
Issued
Licenses 
and 
Options 
Executed
Start-ups
License 
Income 
Received
Michigan State University $515,707,000 5.50 122 49 46 33 1 $3,302,322
Ohio State University $967,306,055 9.00 384 155 62 50 10 $2,105,127
University of Arizona $629,466,000 8.50 144 76 27 48 3 $926,023
University of Florida $544,936,847 13.50 335 152 107 140 16 $28,067,988
University of Iowa $435,377,000 6.00 96 53 24 29 6 $1,205,342
University of Kentucky $239,715,000 2.00 58 17 30 9 3 $4,800,000
University of Michigan $1,328,721,165 9.00 412 148 128 108 9 $14,464,565
University of Minnesota $882,022,000 18.00 331 148 64 91 14 $38,030,470
University of North 
Carolina, Chapel Hill $777,976,677 6.00 138 72 25 56 14 $3,783,545
University of Wisconsin-
Madison $1,123,501,000 18.00 386 167 157 63 7 $94,170,000
*Data obtained from the fiscal year 2013 AUTM report.
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The study herein was designed as a supplement to the previous 
study at the University of Kentucky11 and focused on obtaining a 
more detailed understanding of the impediments to commercializ-
ing research at the university from the perspective of three faculty 
members that have been successful in the continuum of commer-
cialization through successfully obtaining patents, licensing intel-
lectual property and forming start-up companies. The rationale for 
conducting this supplemental study with only successful academic 
entrepreneurs was that we believed that more focused and individu-
alized conversations with such entrepreneurs could provide more 
insight into the commercialization process versus conducting the 
study with individuals that have had more limited or no experience 
in commercializing research.
Methods
The study herein is a supplement to and modeled closely after a 
similar, larger scale study conducted at the University of Kentucky 
specifically among cancer researchers11. The methodology and 
design of the study was qualitative in nature and was based on two 
modules: an online survey (included as Supplementary materials S1) 
followed by a face-to-face interview. It is important to note that 
the prior study11 did not include a face-to-face interview and was 
conducted with faculty that had both successfully commercialized 
their research and those that had not. It is also noteworthy that the 
respondents for this supplemental work span different research 
categories as defined in Table 4. The purpose of this supplemental 
research was to obtain more detailed information, primarily through 
the face-to-face interview, on the impediments to the commerciali-
zation of research at the University of Kentucky.
The selection criteria for inclusion in the study was that the selected 
participants must be faculty members, have active research pro-
grams and be successful academic entrepreneurs based on having 
obtained patents, licensed intellectual property and created start-up 
companies. The research subjects for this study were identified 
through searches of publically available databases containing infor-
mation on the selection criteria. For module one, data were col-
lected and managed using the Research Electronic Data Capture 
(REDCap) tool. REDCap is a secure, Internet-based study-support 
application12. Module two data were recorded in written format dur-
ing the face-to-face interview.
There are several limitations associated with this study. As a limited 
case study designed as a supplement to prior research11, the results 
may not be translatable to other situations or research questions 
beyond that addressed in the original study11, and the opinions of 
the three respondents may not be representative of all the stakehold-
ers involved in the commercialization landscape at the University of 
Kentucky or elsewhere. Thus, the findings may not be generalizable 
to all faculty either at the University of Kentucky or at other univer-
sities, and the findings may or may not be capable of being general-
ized to other research areas. Further, as a cross-sectional study, the 
barriers experienced by the participants outside of the data collec-
tion window may not have been captured. Subject selection bias, 
which could lead to data and outcome bias, may also exist. Lastly, 
the study was designed to identify general challenges, thus more 
specific challenges were likely not captured by this analysis. Despite 
these limitations, the data obtained from this study, especially from 
the face-to-face interviews, provide additional supplemental infor-
mation that enhances the findings of the previous study11. Thus, this 
supplemental work provides more detailed information that can be 
presented to the administrative leadership of the commercialization 
process at the University of Kentucky.
This study was determined to not require review by the Univer-
sity of Kentucky Institutional Review Board. The research subjects 
consented to participate in the study electronically via engagement 
with the online survey and chose to participate in both modules 
of the study. The participants chose to remain anonymous beyond 
interaction with the investigators involved in the study.
Results
Professional productivity and commercialization 
perspective
The first series of survey questions, summarized in Table 3, aimed to 
assess the subjects’ category of research, professional productivity 
and their perspective on research commercialization. Respondent 1 
classified his research as “translational;” he feels satisfied with his 
Table 2. University of Kentucky research commercialization activity, 
2010–2013*.
Commercialization 
Activity 2010 2011 2012 2013
Disclosures 57 59 83 58
Patent Applications 28 22 12 17
Patents Issued 28 26 29 30
Licenses/Options 
Executed 9 8 9 9
Start-ups 6 7 6 3
License Income $2,161,743 $1,544,664 $1,628,264 $4,800,000
*Data obtained from the fiscal year 2010–2013 AUTM reports.
Page 4 of 18
F1000Research 2015, 4:133 Last updated: 11 SEP 2015
Table 3. Professional productivity and commercialization perspective.
Question Respondent 1 Respondent 2 Respondent 3
Which category best describes your research? Translational Basic Basic/Translational
Do you feel that your research results are sufficiently utilized 
through the generation of publications, grants, and other forms of 
professional productivity?
Yes No Yes
Do you intend to commercialize your research in the future? Yes Yes No
Do you think research commercialization is important to promote 
within an academic setting? Yes Yes Yes
Do you think the University of Kentucky places an emphasis on 
academic research commercialization to faculty? No No No
Do you think your research field places an emphasis on academic 
research commercialization? Yes No Yes
Table 4. Impediments to research commercialization.
Potential Barrier Respondent 1 Respondent 2 Respondent 3
There are no barriers to commercializing research at the 
University of Kentucky No No No
There is unwanted risk associated with commercialization Yes No Yes
I lack the expendable time No No Yes
There is excessive expense No No Yes
There is a lack of investors Yes No Yes
There is a lack of infrastructure including facilities and staff to 
help in the commercialization process Yes Yes Yes
Unsupportive University policies, procedures and/or regulations Yes No Yes
Unsupportive federal policies, procedures and/or regulations Yes No No
There is a lack of industry partners No No Yes
Limited or no commercial application of my research exists No No No
There is a lack of importance to academia No Yes No
There is a lack of importance to my field No No No
There is a lack of benefit to society No No No
I have no interest in commercialization No No No
Other barriers not listed Yes Yes No
level of professional productivity in terms of publishing research 
manuscripts, obtaining grant funding and other means of academic 
productivity; and he indicated that he intends to commercialize 
additional research in the future. Despite believing that research 
commercialization is important in the academic setting and that 
his research field values such work, he feels that the University of 
Kentucky places little emphasis on and thus does not greatly value 
research commercialization. Respondent 2 classified his research as 
“basic;” he feels that his research is underutilized; and he intends 
to continue commercializing his work. Further, respondent 2 
believes commercialization is important in an academic setting, 
yet the University of Kentucky does not emphasize such activity 
and he believes that his research field does not place an empha-
sis on commercialization. Respondent 3 classified her research as 
“basic/translational;” she is satisfied with her level of professional 
productivity; and, interestingly, despite having developed intel-
lectual property and starting a company, she indicated that she 
may not pursue the commercialization of her research again in the 
future. Similar to respondent 1, respondent 3 also feels that research 
commercialization is important in the academic setting and that 
her research field values such activity, but that the University of 
Kentucky does not value research commercialization.
Impediments to research commercialization
The second set of survey questions, summarized in Table 4, 
addressed the research subjects’ perceived impediments to commer-
cializing research. Respondent 1 believes that risk, lack of inves-
tors, commercialization infrastructure, unsupportive university and 
Page 5 of 18
F1000Research 2015, 4:133 Last updated: 11 SEP 2015
federal policies, and “other barriers not listed” prohibit his efforts 
to effectively and efficiently commercialize research. Respondent 
2 feels that commercialization infrastructure, lack of importance 
to academia (i.e., lack of emphasis placed on commercialization 
by academia), and “other barriers not listed” are the impediments 
that inhibit his commercialization efforts. The barriers identified by 
respondent 3 include the presence of risk, lack of time, expense, 
lack of investors, insufficient infrastructure, unsupportive univer-
sity policies, and lack of industry partners.
In the face-to-face interview, respondent 1 indicated that the “other 
barriers” included major prohibiting factors such as the lack of 
university support/infrastructure in areas of market analysis, grant 
development, and navigating legal matters including conflict of 
interest and intellectual property ownership issues. Of these “other” 
items, we had anticipated that such factors could be captured under 
the commercialization infrastructure and/or policy categories of 
answer choices in the survey. Ultimately, respondent 1 indicated 
that infrastructure issues are the most significant factors that impede 
research commercialization at the University of Kentucky. The sub-
ject also discussed how some of these barriers are more challenging 
and more difficult to overcome and that he felt that the barriers he 
has encountered are different at other universities. Respondent 2 
indicated three major factors that negatively impact commercializa-
tion at the university and those are: 1) a lack of an entrepreneurial 
culture at the university level which has eroded the interest faculty 
have in pursuing the commercialization of their work; 2) inhibitory 
commercialization policies and an unwillingness for those policies 
to be malleable to individual commercialization situations/circum-
stances; and 3) insufficient and inhibitory commercialization infra-
structure. Respondent 3 described the biggest barriers to academic 
research commercialization as faculty’s lack of business knowledge 
and commercialization background. Interestingly, she considers it 
more the responsibility of each faculty member to drive any poten-
tial commercial aspect of their work rather than rely on resources 
and support that may or may not exist at the university level. Since 
the majority of faculty do not receive any training in business or 
commercialization areas, she feels that this hampers the overall 
commercialization activity on university campuses.
Similar to the previous study among cancer researchers11, these data 
suggest that faculty members experience multiple barriers in the 
commercialization process at the University of Kentucky. Addition-
ally, in comparison with previous studies4–11, the data may suggest 
that not all barriers are consistent or common between individual 
faculty members (for example, expense, time constraints, insuffi-
cient infrastructure, and lack of industry partnerships were the most 
common barriers experienced among University of Kentucky can-
cer researchers11). And, some barriers appear to be more prohibitive 
than others.
Factors that could enhance research commercialization
The final set of questions, summarized in Table 5, were meant 
to determine which impediments would need to be overcome in 
order to increase faculty participation in research commercializa-
tion. Respondent 1 indicated that the barriers in the commercializa-
tion process do not deter him from attempting to commercialize 
his research, however, he believes that reducing/mitigating all 
the potential barriers surveyed, other than addressing royalty pay 
to inventors, would enhance research commercialization activity 
at the University of Kentucky. The subject also indicated that he 
would utilize outside (off campus) commercialization resources to 
lower the barriers he faces in order to improve his commercializa-
tion efforts. Respondent 2 would also use off campus resources to 
enhance his commercialization efforts and he believes that provid-
ing faculty protected time for commercialization efforts, providing 
additional and more helpful information to faculty about how to 
commercialize research, increasing the financial support avail-
able to entrepreneurial faculty, enhancing the commercialization 
infrastructure on campus, and increasing the emphasis placed on 
research commercialization would improve the commercialization 
activity at the university. Similar to respondents 1 and 2, respondent 
3 would use off campus resources to commercialize her research, 
and she feels that providing information on how to commercialize, 
Table 5. Factors that could enhance research commercialization.
Factor Respondent 1 Respondent 2 Respondent 3
Offering protected time specifically for commercialization activities Yes Yes No
Increasing information on how to commercialize Yes Yes Yes
Increasing financial support Yes Yes Yes
Better and/or more infrastructure including facilities and staff to 
help in the commercialization process Yes Yes Yes
Revising university policies, procedures and/or regulations Yes No Yes
Revising federal policies, procedures and/or regulations Yes No No
Increasing links to industry Yes No Yes
Increasing emphasis placed by academia and/or my research 
field on the importance of research commercialization Yes Yes No
Greater personal benefits including more royalty pay No No No
Greater societal benefits Yes No No
Nothing would help No No No
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providing financial support, improving commercialization infra-
structure, revising university policies, and increasing links to indus-
try would improve commercialization activity at the University of 
Kentucky.
These data are similar to the feelings reported by cancer researchers11 
in which respondents believe that mitigating many factors would 
presumably increase commercialization activity. Not all respond-
ents, however, completely agree on all the factors that are important 
to address.
Conclusion
This case study investigated the mindset of three successful aca-
demic entrepreneurs at the University of Kentucky in relation to 
the status of the research commercialization process and in context 
with the university’s general commercialization activity. The gen-
eral state of the institution’s commercialization activity is modest 
relative to its benchmark institutions and stagnant in growth over 
time. The research subjects identified several factors that generally 
impede research commercialization and the subjects agreed that 
mitigating many factors may increase commercialization activity. 
Infrastructure insufficiencies, a lack of an emphasis by the univer-
sity on the importance of research commercialization, a low to non-
existent entrepreneurial culture on campus, inhibitory policies, and 
a lack of business and commercialization knowledge among faculty 
were highlighted as the most significant barriers. While generally 
fitting with the impediments found at other universities and among 
cancer researchers at the University of Kentucky4–11, the results sug-
gest that not all barriers are common or consistent between faculty 
and that some impediments may be more prohibitive than others. 
It is likely that the barriers vary between and among disciplines 
and the barriers may further vary based on an individual’s general 
experience with the commercialization process.
These data can be shared with the University of Kentucky’s Intel-
lectual Property Development and Technology Transfer Office and 
the Office of the Vice President for Research and used as a guide 
to make changes that will improve the research commercialization 
process. The research subjects’ comments regarding commerciali-
zation infrastructure, a stagnant entrepreneurial culture, inhibi-
tory commercialization policies, and faculty’s lack of business/ 
commercialization knowledge may be particularly important to 
address in order to enhance commercialization activity at the 
university. Additionally, similar work could be conducted at and 
among other institutions. For example, a survey similar to the one 
herein and that used in the prior study11 could be incorporated into 
the yearly AUTM licensing survey in order to gauge, on a much 
broader scale, the impediments to academic research commerciali-
zation as well as to understand how other institutions are mitigating 
such impediments. Understanding how institutions that are highly 
successful in commercializing research mitigate barriers in the 
process would be greatly beneficial to institutions that have low to 
modest commercialization activity.
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with 3 entrepreneurial respondents as opposed to a larger cohort of cancer researchers in the previous
UK study.
The updated information from 2 more respondents is appreciated, but ideally it would be nice to have a
larger group than 3. Getting information from those that had a positive and a negative experience is
helpful to make changes to the system. If the ultimate goal is to provide this feedback to the UK TTO in
order to institute changes, more details would be helpful. Some aspects that I think would benefit from
further detail are the following:
Interviews of the actual TTO employees? What is keeping the University from making any
changes?
 
Some background information on what other universities have done to rebrand their TTO. There
have been many stories regarding offices doing an overhaul and rebranding and trying new things.
Table 5 is a good start in figuring out some areas that need more improvement. A section that
details what other offices have tried would be useful to people in technology transfer. The
suggestions listed in table 5 are fairly standard practices that TTOs must consider. Can you include
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suggestions listed in table 5 are fairly standard practices that TTOs must consider. Can you include
suggestions of how other universities have for instance increased links to industry or how they
have offered more information to researchers teaching them how to commercialize? What are the
policies or regulations that are restrictive at UK? Would utilizing more interns/students/post docs as
staff help in bringing in more disclosures or provide more hands to evaluate inventions?
Overall the authors claim that the goal is to present this data as a guide to the UK TTO to make changes.
It would be helpful to provide suggestions rather than telling them these results which they likely already
know and realize are a problem.  It will be more useful to also provide some options that have been tried
by other universities rather than just pointing out the failures. With these additions I think the article would
be much stronger and more useful to other TTO offices.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Version 1
 01 July 2015Referee Report
doi:10.5256/f1000research.6961.r9270
 Evan Facher
Enterprise Development, University of Pittsburgh, Pittsburgh, PA, USA
The study by Vanderford and Marcinkowski attempts to identify challenges to the commercialization of
innovations discovered at their institute of higher learning, the University of Kentucky. The goal of this
work is to improve the sluggish local climate for translation of discoveries by communicating the findings
resulting from this effort back to administrative leadership with the hope that the identification of these
impediments leads to real change. By deploying a survey and subsequent interviews the authors plan to
generate learnings sufficient to form the basis of their recommendations.
 
Movement of research discoveries from academic institutes to the marketplace is important not only for
these discoveries to have their societal impact but also to drive economic growth of a region. The
juxtaposition of most new jobs created over the last two decades coming from startup companies and
much innovation from academia serving as the impetus for these new entities hints at the regional
criticality of a university being able to successfully translate its discoveries into products reaching the
market.
 
While the Vanderford and Marcinkowski article has a solid thesis and very good intent, it is however
limited (in this reviewers mind) by a handful of items. First, the conclusions the authors generate are
based on the survey and interview of a single academic entrepreneur. The data achieved from this
individual is certainly very valuable but it might not be reflective of the other individuals on campus that
have had experiences with commercialization of university-based research. The challenges described by
this individual on campus ring true of the commercialization issues found throughout other academic
organizations; however due to the small sample size it is hard to draw solid conclusions for the University
of Kentucky as a whole. As one of the aims of the study is to report findings back to the administration
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organizations; however due to the small sample size it is hard to draw solid conclusions for the University
of Kentucky as a whole. As one of the aims of the study is to report findings back to the administration
with the goal of impacting change, I would suggest that the senior leadership, while sympathetic to the
challenges expressed by the authors, will not institute changes based on such a small set of data that
may not accurately reflect the general experiences of its academic entrepreneurs in totality.
 
I would recommend that the authors attempt to increase the number of study subjects to enhance the
power of their research. In addition to surveys/interviews with academics that have successfully
commercialized their innovations on campus, I would strongly urge the authors to include a set of
individuals that have had unsuccessful experiences as well. Learnings from this cohort might provide an
additional set of data to further drive the goals of enhancing translation at their institute.
 
The second item I would suggest the authors to contemplate in their assessments is expanding their
perspectives on reasons for an innovation not being commercialized. It seems as if the main focus of the
surveys/interviews is on structural elements involved in the workflow for moving a university idea to
commercialization. It is often that the main reason for the lack of translation has nothing to do with the
internal processes for moving the opportunity forward but rather that the innovation never really
addressed a true market need despite the solid academic research. As such, regardless of the view of
commercialization risk, the number of investors, the supportiveness of university policies or facilities/staff
to advance the process, the idea itself is not commercialized because it does not contain a value
proposition for any outside entity to take hold of. It is imperative to identify a product-market fit for an
innovation as not all concepts should become companies and not all ideas impact the market. A strong
technology translation capability cannot make up for an opportunity without a direct connection to an
existing customer pain-point, which is only identified through a process of customer discovery outside of
the university’s walls.
 
Lastly, from a practical perspective, I would recommend that as part of the engagement with a larger set
of academic entrepreneurs on campus (both successful and unsuccessful), the survey/interview deployed
by the authors engage these individuals in soliciting programs, opportunities, efforts, and ideas to improve
the existing stagnant innovation culture on campus. I believe by engaging these “customers” on campus
in dialogue focused on solving the challenge, administrative support will be more easily achieved.
 
In conclusion, I believe the authors are on the right track and that their efforts have significant merit. I
would urge them to continue their work, expand the sample size, examine a bit broader set of reasons
why the problems exist and work with their respondents to improve the situation.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 04 Aug 2015
, University of Kentucky, USANathan Vanderford
Dear Dr. Facher,
Thank you for your time and comments. Your critique has helped guide us through revising the
article. We would like to directly respond to some of your comments. We would first like to clarify
that this case study was designed and conducted as a supplement to the  looking at theprior study
barriers associated with cancer research commercialization at the University of Kentucky (we have
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barriers associated with cancer research commercialization at the University of Kentucky (we have
made this clarification in the new version of the article). The prior study’s conclusions were based
solely on the responses to the survey as individual interviews were not conducted. Thus, the intent
of the current study was to collect more specific, supplemental information through interviews with
“successful” entrepreneurs. Given this intent and the study’s supplemental nature, we have
purposefully not incorporated new research questions into the current case study. We have,
however, at your suggestion, expanded the sample size by two respondents and this generated a
number of additional significant comments that are important to understand regarding the
university’s low commercialization rate. We agree with your assertions that additional reasons for
low commercialization activity likely exist and that expanding our research questions and sample
size to include a mix of stakeholders involved in the research commercialization process (including
faculty that have been unsuccessful at commercializing their research and staff/administrators of
the commercialization process, etc.) would aid in uncovering other issues. We would like to note,
however, that expansion of this current work would change the intent (described above) and
design of our study. Therefore, we have maintained the overall intent and design of the study other
than adding the additional respondents. We believe that this design will allow us to bring some
additional closure to the . Lastly, to offset additional concerns, we have included aprior study
description of the limitations of this case study in the methods sections.
 
In closing, we hope that you will review this revised version of the article in light of our changes
based on your comments as well as those of the other two reviewers (we hope that you will read
the other reviewers’ comments as well as our response to those reviews) and in relation to its
intended purpose of being a supplemental component to the  at the University ofprior study
Kentucky.
 
Sincerely,
Nathan L. Vanderford and Elizabeth Marcinkowski 
 No competing interests were disclosed.Competing Interests:
 17 June 2015Referee Report
doi:10.5256/f1000research.6961.r9005
 Scott Crick
Licensing Associate, Office of Technology Management, Washington University, St Louis, MO, USA
This study attempted to identify potential impediments to commercialization of research at the University
of Kentucky. The authors point out that, according to data from AUTM, the University of Kentucky ranks
near the bottom in a number of key metrics of commercialization when compared to its benchmark
institutions.  The goal of the study was to identify barriers to commercialization. These findings will then be
brought to administration in hopes of rectifying the problem.
I think there are several issues with this work that, if addressed properly, will greatly strengthen its impact
and utility not only at UK but also at other university technology transfer organizations. 
The first issue I have with the work is the inclusion of only a single faculty member with entrepreneurial
experience. The rationale given was that that person could provide more insight into the process as a
whole.  Looking at the data referenced in Table 1, the most striking discrepancy between UK and
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whole.  Looking at the data referenced in Table 1, the most striking discrepancy between UK and
benchmark institutions is the number of invention disclosures.  When the data are normalized to the
number of invention disclosures per institution, UK appears to be making good use of the inventions that
are disclosed to them. It seems to me that one of the major issues at UK is simply getting inventors. While
I agree that the entrepreneurial faculty member could have a lot of insight into issues after the first step, I
wonder how much insight this person provided with regards to why people are not disclosing inventions. I
am certain it would be possible to identify faculty that publicly disclosed potentially valuable assets
without ever filing an invention disclosure, and I would suggest understanding those issues are 1)
extremely important for improving commercialization at UK, and 2) more easily addressable at an
institutional level than some other potential barriers.
The second issue with relying on input from a single faculty member is that barriers are variable (as even
mentioned in the article) not only between individuals, but between disciplines and sub-disciplines as
well.  Although the individual faculty member can identify barriers he/she has experienced, it would be
disingenuous to suggest these barriers and the relative weight given to each of them is an accurate
reflection of the system as a whole. A minor point....It would also be very helpful to know general field of
research of the faculty member interviewed. "Translational" is very broad. Is he/she in pharma, biotech,
medical devices, engineering...?
I have two recommendations to strengthen this article. 
My first recommendation is that the authors include in the case study at least two other faculty members
with technology commercialization experience (not necessarily on par with the initial interviewee). I would
also suggest that these faculty be from distinct research areas and departments. Although still qualitative,
it would be insightful to see if these people with different types of technology, different department
makeup, and very likely different experiences and backgrounds still identify the same barriers.
My second recommendation is to limit the scope to barriers that are perceived after invention disclosure.
It appears as though there is an issue at UK (which I should say is certainly not unique) that I suspect has
to do with education of potential inventors such that a number of these people are not even considering
that their technology might have commercialization potential. A follow-up study trying to tease apart this
issue would be interesting and may have broader appeal.    
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 04 Aug 2015
, University of Kentucky, USANathan Vanderford
Dear Dr. Crick,
 
We thank you for taking the time to review our case study. Your critique has helped shape our
current version of the article. We would like to respond to some of your comments. First, per your
suggestion, we have expanded our sample size by two respondents. This expansion lead to the
collection of a significant amount of additional crucial comments that are important to understand
about the issues related to the low commercialization activity at the University of Kentucky.
Second, in regard to your question about the respondents’ field of research, we understand your
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Second, in regard to your question about the respondents’ field of research, we understand your
desire to have more information regarding the respondents’ research areas, but we feel that for
confidentiality purposes, we cannot be any more specific; given the small sample size of
“successful” academic entrepreneurs at the University of Kentucky, reporting a respondent’s
specific research field could potentially allow for the identification of the subject. Next, you made
very insightful comments regarding the desire to better understand the issues involved in the
university’s low invention disclosure rate. We agree with your points and we would also like to
address this issue. With that said, however, we would like to clarify that this case study was
designed and conducted as a supplement to the  looking at the barriers associated withprior study
cancer research commercialization at the University of Kentucky; the sole intent of the current
study was to collect more specific, supplemental information through interviews with the
respondents (we have now explicitly stated this intent in the new version of the article). Given this
intent and the study’s supplemental nature, we have purposefully not incorporated new research
questions into the current case study. We feel that expanding the current study would likely change
its primary intent. We do hope to address additional research questions, including understanding
issues related to the low disclosure rate, in future work. Lastly, to offset additional concerns, we
have included a description of the limitations of this case study in the methods sections.
 
In closing, we hope that you will review this revised version of the article in light of our changes
based on your comments as well as those of the other two reviewers (we hope that you will read
the other reviewers’ comments as well as our response to those reviews) and in relation to its
intended purpose of being a supplemental component to the  at the University ofprior study
Kentucky.
 
Sincerely,
Nathan L. Vanderford and Elizabeth Marcinkowski 
 No competing interests were disclosed.Competing Interests:
 05 June 2015Referee Report
doi:10.5256/f1000research.6961.r8827
 Jessica Silvaggi
UWM Research Foundation, Milwaukee, WI, USA
The goal of the authors was to document any impediments to the commercialization process at the
University of Kentucky. The study was spurred by the findings that UK significantly underperforms when
compared to peer institutions of similar size. A previous study was published in 2013 regarding this same
topic at UK for the commercialization of cancer research. In this study, similar surveys were conducted
with one single entrepreneurial respondent as opposed to a larger cohort of cancer researchers in the
previous UK study.
They report that the major issue impeding commercialization, according to the respondent, is the lack of
appropriate infrastructure at the university. The results were apparently similar to those found in this 2013
paper. I found this topic to be of great interest in comparing the performance to schools of similar
benchmarks. The results could be helpful to many institutions that are underperforming and looking to
boost commercialization. The survey questions used could be useful for any institution to keep track of the
satisfaction of the researchers in regard to commercialization of their technologies, and to assess the
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satisfaction of the researchers in regard to commercialization of their technologies, and to assess the
adequacy of the performance of the technology transfer office.
Major concerns/Revisions
While I think the survey questions used were reasonable, I have doubts about the validity of asking
a single entrepreneur the survey questions. It comes across as if the same 2013 study was
repeated, but with only one person. I don’t feel that one person is a significant number for this type
of paper to make conclusions with. N=1 doesn’t seem to be a true scientific sampling.
Unfortunately, if more respondents were utilized, then this paper would appear to be a repeat of the
earlier study. Perhaps another angle would be to survey the staff at UK as to why they are
underperforming. Asking the tech transfer professionals and other research administrators would
also be informative and provide a different angle to the original survey of cancer researchers. Or
perhaps a broader survey of other departments would be helpful, rather than only focusing on the
cancer department.
 
I feel that several other angles could have also been explored in this paper to contrast or follow up
on the work in the 2013 paper about UK. After the first study were any changes made based on the
conclusions? Did the number of staff change? Did any of the infrastructure change at UK? Did UK
do anything to increase the level of commercialization? There are many other interesting questions
that could be explored rather than repeating the study over again with one participant.
 
If the university has not responded to the previous study in any fashion, I find that of great interest. 
Why hasn’t the technology transfer office been expanded and further supported? Why is there no
incentive by those in charge of this area to revamp the office? There has been a large push at
many universities to further promote entrepreneurship in faculty and students and support
commercialization. In some online information it states that in the past UK was pushing to be a top
20 university by 2020. I am curious to know why there has been no change in the recent years.
Minor Revisions
When comparing benchmarks, another important factor missing in the table is the amount of
research dollars. There is a ratio of expected disclosures per millions of dollars of research which
varies, but is quoted in several locations at 1 disclosure per $1.5M-$3M and 1 start-up company
per ~$100M. Knowing the amount of research dollars going into UK would help to show a lack of
productivity with inventions at the university.  This information should be available through AUTM if
not through the technology transfer office directly. Based on some online information the research
expenditures at UK appear to be in the hundreds of millions of dollars. Assuming ~$400M in
expenditures, one would expect about 130 disclosures. The UK website cites 84 disclosures in
2014.
Summary:
I feel that major revisions are necessary for this paper to add some new information and expand the
scope of the study. The results here do not seem to add onto those previously found but simply confirm
the previous findings with the survey of one entrepreneurial researcher. A different sample of respondents
would greatly enhance this paper such as asking researchers from all departments, or focusing on the
staff involved in technology transfer, commercialization and entrepreneurship. Or perhaps if changes
were made by the tech transfer office and these did not have an effect, this would be good to know for
other offices. There appears to be something missing from this story. This paper would be of interest if
revamped to add a new twist distinct from the 2013 paper.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an
acceptable scientific standard.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 04 Aug 2015
, University of Kentucky, USANathan Vanderford
Dear Dr. Silvaggi,
 
We greatly appreciate the time you dedicated to review our article. We found your comments very
helpful as we revised the article. We are happy that you found this topic of interest and applicable
to other institutions. Before reading the new version, we would like to address some of your
comments and concerns. First, we appreciate your concerns regarding the “n-of-1” design of the
study. As suggested by each reviewer, we have added two additional respondents to the study and
this did indeed generate several additional important points regarding the issues related to the low
commercialization activity at the University of Kentucky. Second, we appreciate your comments
regarding how this work could be construed as a repeat of the . We agree with yourprior study
assertions that other issues are likely involved in the low commercialization activity at the university
and we agree that surveying a mix of stakeholders involved in the research commercialization
process could aid in uncovering other issues. However, we would like to clarify that this case study
was, in fact, specifically designed and conducted as a supplement to the  looking at theprior work
barriers associated with cancer research commercialization at the University of Kentucky (we have
made this clarification in the new version of the article). The prior study’s conclusions were based
solely on the responses to the survey and individual interviews were not conducted. The intent of
the current study was to collect more specific, supplemental information through interviews. Given
this intent and the study’s supplemental nature, we have purposefully not incorporated new
research questions into the current case study. We believe that future work would best address
many of your comments which add additional research questions that would help understand other
issues that may be connected to the low research commercialization activity. You have also made
several important comments regarding whether the university has made any changes in the
research commercialization process since the . In fact, few changes have been made2013 study
and that is one reason why it was important to conduct this case study; it was important to obtain
specific comments from “successful” entrepreneurs so that these individuals could identify specific
issues in the system. Finally, to offset additional concerns, we have included a description of the
limitations of this case study in the methods sections. Per your minor point, we have now also
added research expenditures to Table 1.
 
In closing, we hope that you will review this revised version of the article in light of our changes
based on your comments as well as those of the other two reviewers (we hope that you will read
the other reviewers’ comments as well as our response to those reviews) and in relation to its
intended purpose of being a supplemental component to the  at the University ofprior study
Kentucky.
 
Sincerely,
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Sincerely,
Nathan L. Vanderford and Elizabeth Marcinkowski 
 No competing interests were disclosed.Competing Interests:
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